App attack on diabetes: 30 young adults test digital lifestyle fix
NCT ID NCT07604012
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a mobile health app designed to help young adults (ages 20-35) reduce their risk of type 2 diabetes. The app provides guidance on nutrition, physical activity, sleep, and stress management. Researchers will compare changes in quality of life and blood sugar levels between the app users and a control group.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- mHealth app with nutrition, physical activity, sleep, and stress management modules
- What this could lead to
- If it works, this could offer a simple, scalable way to lower diabetes risk in young adults using a smartphone app.
- What could go wrong
- This is a very small early trial (30 people) with no phase, so results may not apply broadly. The app's impact on actual diabetes prevention is uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 35 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Young adults aged between 20-35 years, as defined by the WHO. * At risk of diabetes based on self-reported family history or lifestyle habits. * Participants who are willing to engage in the mHealth intervention program. * Own a smartphone and are familiar with using mobile apps. * Complete the informed consent process, agreeing to follow the study protocol, including survey completion and health assessment. Exclusion Criteria: * Individuals diagnosed with chronic mental or physical illnesses * Individuals with hearing or vision loss so severe that they could not access the mobile health intervention. * Pregnant women or women who plan on becoming pregnant during the study. * Individuals who are already taking part in an equivalent diabetes or health programme. * Individuals who are not willing to provide consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Type 2 diabetes risk reduction in young adults are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University
Rawalpindi, Punjab Province, 46000, Pakistan